Concussion is considered a ‘mild’ injury, but effects can last a lifetime, especially with multiple impacts. Understanding ...

Axons, the fundamental output structures of neurons, play a pivotal role in transmitting electrical signals over long distances without attenuation in the nervous system. Beyond their classical role ...

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...

Nura Bio has secured an additional $68m in a Series A financing round to advance the development of its neuroprotective ...

Violent blows or jolts to the head can cause traumatic brain injury (TBI), and there are currently about five million people ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion ...

The funding will support mid-stage testing of a drug the company believes to have the potential to treat a range of neurodegenerative conditions.

The funding will support mid-stage testing of a drug the company believes to have the potential to treat a range of ...

Stock of Applied Therapeutics, Inc. surges as FDA skips AdCom for AT-007 in galactosemia. Read more on recent developments ...

Nura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million ...